Valeritas & #226; �(TM) V-Go & #194; & #174; Wearable Insulin Delivery Device, Combined ...

BRIDGEWATER, N.J., Nov. 03, 2017 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies, announced today positive findings from a analysis conducted combining its V-Go® Wearable Basal plus Bolus Insulin Delivery Device with a weekly physician-driven, simplified prandial-focused insulin titration algorithm. Achievement of glycemic targets...This story is related to the following:Medical Devices |
Source: Industrial Newsroom - Health, Medical and Dental Supplies - Category: Medical Devices Source Type: news